Back
EastGroup Properties 10K Form
Buy
59
EGP
EastGroup Properties
Last Price:
171.79
Seasonality Move:
5.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-24 | 10Q | EGP/EastGroup Properties Quarterly |
2023-10-25 | 10Q | EGP/EastGroup Properties Quarterly |
2023-07-26 | 10Q | EGP/EastGroup Properties Quarterly |
2023-04-26 | 10Q | EGP/EastGroup Properties Quarterly |
2022-10-26 | 10Q | EGP/EastGroup Properties Quarterly |
2022-07-27 | 10Q | EGP/EastGroup Properties Quarterly |
Receive EGP News And Ratings
See the #1 stock for the next 7 days that we like better than EGP
EGP Financial Statistics
Sales & Book Value
Annual Sales: | $570.59M |
---|---|
Cash Flow: | $122.93M |
Price / Cash Flow: | 20.63 |
Annual Sales: | $57.56 |
Price / Book: | 3.01 |
Profitability
EPS (TTM): | 4.84000 |
---|---|
Net Income (TTM): | $232.57M |
Gross Margin: | $416.56M |
Return on Equity: | 8.78% |
Return on Assets: | 5.07% |
EastGroup Properties Earnings Forecast
Key EastGroup Properties Financial Ratios
- The Gross Profit Margin over the past 18 years for EGP is 73.01%.
- The Selling, General & Administrative Expenses for EGP have been equal to 3.04% of Gross Profit Margin.
- The Interest Expense is 22.47% of Operating Income.
- The Net Earning history of EGP is 35.14% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 20 years.
EastGroup Properties Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Industrial REITs |
Sector: | Real Estate |
Current Symbol: | EGP |
CUSIP: | 277276 |
Website: | eastgroup.net |
Debt
Debt-to-Equity Ratio: | 0.57 |
---|---|
Current Ratio: | 0.57 |
Quick Ratio: | 0.49 |
Price-to-Earnings
Trailing P/E Ratio: | 38.91 |
---|---|
Forward P/E Ratio: | 35.23 |
EGP Technical Analysis vs Fundamental Analysis
Buy
59
EastGroup Properties (EGP)
is a Buy
Is EastGroup Properties a Buy or a Sell?
-
EastGroup Properties stock is rated a Buy
The current EastGroup Properties [EGP] share price is $171.98. The Score for EGP is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.